Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Tirzepatide, a dual GLP-1 and GIPR agonist, reaches a maximum dose of 15 mg weekly via subcutaneous injection
Draw air into the syringe equal to the dose, inject the air into the vial, then draw up the correct insulin dose into the syringe
Dietary folate drives methionine metabolism to promote cancer development by stabilizing MAT IIA
How GLP-1 medicines work, in plain language GLP-1 receptor agonists reduce appetite, slow gastric emptying, and improve blood sugar control by mimicking a gut hormone that signals fullness
Regular exercise may help restore glutathione levels and improve antioxidant activities
Supports GLP-1 pathway naturally Formulated for weight loss and appetite suppression Third Party Tested Get to your weight goals naturally without side effects and large expense
